Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-FR
Language English French
Date Updated 2019-04-23 2019-03-06
Drug Identification Number 02318121 02318121
Brand name ROCURONIUM BROMIDE INJECTION ROCURONIUM BROMIDE INJECTION
Common or Proper name Rocuronium Rocuronium
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients ROCURONIUM BROMIDE ROCURONIUM BROMIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 5mL Vial 10 x 5mL Vial
ATC code M03AC M03AC
ATC description MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-03-19 2019-03-19
Actual start date 2019-04-23
Estimated end date 2019-07-02 2019-05-17
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments